Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026)

Macrogenics' (MGNX) quarterly Change in Acquisitions & Divestments came in at $47.6 million in Q1 2026, up 159.69% year-on-year from $18.3 million in Q1 2025, and up 106.34% on a QoQ basis from $23.1 million in Q4 2025.

Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends

Macrogenics (MGNX) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $47.6 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 159.69% year-over-year to $47.6 million in Q1 2026; TTM through Mar 2026 was $125.4 million, a 4.7% decrease from a year earlier, with the FY2025 full-year figure at $96.1 million, down 49.41% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $47.6 million, up from $23.1 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for MGNX reached as high as $76.8 million in Q1 2024 and fell as low as $8.6 million in Q2 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $40.6 million across 5 years, with a median of $41.0 million in 2024.
  • Across the five-year window, Change in Acquisitions & Divestments surged 222.29% in 2024 and tumbled 84.77% in 2025, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at $39.8 million in 2022, then soared by 55.75% to $61.9 million in 2023, then tumbled by 74.36% to $15.9 million in 2024, then jumped by 45.44% to $23.1 million in 2025, then jumped by 106.34% to $47.6 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $47.6 million in Q1 2026, $23.1 million in Q4 2025, and $46.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn -
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn
7 Belite Bio 63.28 Bn 63.28 Bn -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn -
10 Macrogenics 249.36 Mn 182.84 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 47.64 Mn
Mar 31, 2026 47.64 Mn
Dec 31, 2025 23.09 Mn
Dec 31, 2025 23.09 Mn
Sep 30, 2025 46.12 Mn
Sep 30, 2025 46.12 Mn
Jun 30, 2025 8.59 Mn
Jun 30, 2025 8.59 Mn
Mar 31, 2025 18.35 Mn
Mar 31, 2025 18.35 Mn
Dec 31, 2024 15.88 Mn
Dec 31, 2024 15.88 Mn
Sep 30, 2024 41.00 Mn
Sep 30, 2024 41.00 Mn
Jun 30, 2024 56.40 Mn
Jun 30, 2024 56.40 Mn
Mar 31, 2024 76.75 Mn
Mar 31, 2024 76.75 Mn
Dec 31, 2023 61.91 Mn
Dec 31, 2023 61.91 Mn